Publications by authors named "Atsuko Inamoto"

Claim this Profile
H
Halved Dose of Antipsychotics Versus High-Dose Antipsychotic Therapy for Relapse in Patients with Schizophrenia Receiving High-Dose Antipsychotic Therapy: A Randomized Single-Blind Trial.
Ryota Ataniya, Takeshi Koike, Atsuko Inamoto

Int J Mol Sci· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constipation-associated factors in outpatients with schizophrenia: A multicenter questionnaire survey.
Taro Tazaki, Hiroki Yamada, Ryotaro Sato, Hiroki Ishii, Shutaro Sugita, Atsuko Inamoto

Neuropsychopharmacol Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity-associated factors in psychiatric outpatients: A multicenter questionnaire survey.
Hiroki Ishii, Hiroki Yamada, Ryotaro Sato, Wakaho Hayashi, Dan Nakamura, Atsuko Inamoto

Neuropsychopharmacol Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil-Lymphocyte Ratio in Patients With Acute Schizophrenia.
Shutaro Sugita, Hiroi Tomioka, Kensuke Mera, Taro Tazaki, Hana Nishiyama, Atsuko Inamoto

Cureus· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Parity and Postpartum Depression on Mother-Infant Bonding in the First Month Postpartum: A Retrospective Study.
Keita Kawai, Hiroi Tomioka, Hiroki Yamada, Sho Mamiya, Azumi Kato, Atsuko Inamoto

Cureus· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lemborexant as an alternative drug for patients with insomnia taking gamma-aminobutyric acid-benzodiazepine receptor agonists or suvorexant.
Kazumaro Okino, Hirohisa Suzuki, Hiroi Tomioka, Kenji Sanada, Keita Kawai, Atsuko Inamoto

Hum Psychopharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of change from suvorexant to lemborexant drug in the treatment of sleep disorders.
Kazumaro Okino, Hirohisa Suzuki, Seiji Kondo, Hiroi Tomioka, Takahiro Tokumasu, Atsuko Inamoto

Psychogeriatrics· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for readmission in schizophrenia treated with combined psychoeducation and standard therapy.
Satoru Sugisawa, Tatsuya Kurihara, Yukako Nakano, Toshiaki Tsuneoka, Hiroaki Koya, Atsuko Inamoto

Neuropsychopharmacol Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Suvorexant and Antipsychotics in the Treatment of Delirium After Infectious Diseases: A Retrospective Study.
Kazumaro Okino, Hiroki Yamada, Hiroi Tomioka, Shinji Nozaki, Akira Iwanami, Atsuko Inamoto

J Clin Psychopharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asphyxia risk factors in adult psychiatric wards.
Satoru Sugisawa, Shinji Nozue, Tatsuya Kurihara, Hiroaki Koya, Toshiaki Tsuneoka, Atsuko Inamoto

Perspect Psychiatr Care· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Anticholinergic Activity as an Index of Anticholinergic Activity Load in Alzheimer's Disease.
Mitsugu Hachisu, Kimiko Konishi, Misa Hosoi, Masayuki Tani, Hiroi Tomioka, Atsuko Inamoto

Neurodegener Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypothesis of Endogenous Anticholinergic Activity in Alzheimer's Disease.
Kimiko Konishi, Koji Hori, Masayuki Tani, Hiroi Tomioka, Yuka Kitajima, Atsuko Inamoto

Neurodegener Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacotherapy for Neurocognitive Disorders Based on the Hypothesis of Endogenous Appearance of Anticholinergic Activity.
Misa Hosoi, Koji Hori, Kimiko Konishi, Masayuki Tani, Hiroi Tomioka, Atsuko Inamoto

Neurodegener Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of the Role of Anticholinergic Activity in Lewy Body Disease and Delirium.
Yuka Kitajima, Koji Hori, Kimiko Konishi, Masayuki Tani, Hiroi Tomioka, Atsuko Inamoto

Neurodegener Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticholinergic Activity and Schizophrenia.
Masayuki Tani, Norihisa Akashi, Koji Hori, Kimiko Konishi, Yuka Kitajima, Atsuko Inamoto

Neurodegener Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demonstrating the Role of Anticholinergic Activity in a Mood Disorder.
Koji Hori, Kimiko Konishi, Takahiro Hanashi, Masayuki Tani, Hiroi Tomioka, Atsuko Inamoto

Neurodegener Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond the Hypothesis of Serum Anticholinergic Activity in Alzheimer's Disease: Acetylcholine Neuronal Activity Modulates Brain-Derived Neurotrophic Factor Production and Inflammation in the Brain.
Mitsugu Hachisu, Kimiko Konishi, Misa Hosoi, Masayuki Tani, Hiroi Tomioka, Atsuko Inamoto

Neurodegener Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Cholinesterase Activity in Alzheimer's Disease.
Misa Hosoi, Koji Hori, Kimiko Konishi, Masayuki Tani, Hiroi Tomioka, Atsuko Inamoto

Neurodegener Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Cognitive Dysfunction Caused by Anticholinergic Burden in Japanese Alzheimer's Disease Patients, Using the Most Commonly Used Scales in Japan.
Kimiko Konishi, Koji Hori, Mitsugu Hachisu, Hiroi Tomioka, Masayuki Tani, Atsuko Inamoto

Nihon Shinkei Seishin Yakurigaku Zasshi· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Investigation of community support measures for patients with comorbid substance use disorder and psychotic disorder: nationwide survey of drug addiction rehabilitation centers].
Tomohiro Ikeda, Junko Koike, Minoru Kouda, Atsuko Inamoto, Nobuaki Morota

Nihon Arukoru Yakubutsu Igakkai Zasshi· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P300 component of event-related potentials in persons with asperger disorder.
Akira Iwanami, Yuka Okajima, Haruhisa Ota, Masayuki Tani, Takashi Yamada, Atsuko Inamoto

J Clin Neurophysiol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A study of the rehabilitation support system for illegal substance use disorder patients from the viewpoint of the designated hospital. 4 case studies focusing on judicial treatment and drug urine monitoring].
Tomohiro Ikeda, Junko Koike, Nobuaki Morita, Kazuhiro Yamamoto, Yuzo Aikawa, Atsuko Inamoto

Nihon Arukoru Yakubutsu Igakkai Zasshi· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Misalignments of rest-activity rhythms in inpatients with schizophrenia.
Manami Kodaka, Satoshi Tanaka, Madoka Takahara, Atsuko Inamoto, Shuichiro Shirakawa

Psychiatry Clin Neurosci· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis